Cargando…

The fourth vaccination with a non-SARS-CoV-2 variant adapted vaccine fails to increase the breadth of the humoral immune response

Escape mutations in the spike protein of SARS-CoV-2 are a major reason for Omicron breakthrough infections. After basal vaccination only very low titers of Omicron neutralizing antibodies are present. However, booster vaccinations induce higher titers against the Omicron variant. The neutralization...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hein, Sascha, Sabino, Catarina, Benz, Nuka Ivalu, Görgülü, Esra, Maier, Thorsten Jürgen, Oberle, Doris, Hildt, Eberhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319856/ https://www.ncbi.nlm.nih.gov/pubmed/37402816 http://dx.doi.org/10.1038/s41598-023-38077-x

Ejemplares similares

Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination
por: Hein, Sascha, et al.
Publicado: (2022)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
por: Hastert, Florian D., et al.
Publicado: (2022)

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021)

Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera
por: Herrlein, Marie-Luise, et al.
Publicado: (2022)

Omicron’s message on vaccines: Boosting begets breadth
por: Wesemann, Duane R.
Publicado: (2022)

Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19
por: Zahn, Tobias, et al.
Publicado: (2021)

Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity
por: Awad, Gounwa, et al.
Publicado: (2021)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Finite neutralisation breadth of omicron after repeated vaccination
por: Zhu, Yufang, et al.
Publicado: (2022)

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
por: Joo, Yoosun, et al.
Publicado: (2023)

Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response
por: Kusi, Kwadwo A., et al.
Publicado: (2010)

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses
por: Rollier, Christine S., et al.
Publicado: (2016)

Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination
por: Mantus, Grace, et al.
Publicado: (2022)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

In Depth Breadth Analyses of Human Blockade Responses to Norovirus and Response to Vaccination
por: Haynes, Joel, et al.
Publicado: (2019)

Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response
por: Su, Lynn, et al.
Publicado: (2023)

A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain
por: Wang, Ji, et al.
Publicado: (2022)

The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
por: Cohen, Idan, et al.
Publicado: (2023)

Inhibition of Zika Virus Replication by Silvestrol
por: Elgner, Fabian, et al.
Publicado: (2018)

Bafilomycin A1 and U18666A Efficiently Impair ZIKV Infection
por: Sabino, Catarina, et al.
Publicado: (2019)

Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years
por: Bar-Haim, Erez, et al.
Publicado: (2022)

(347) Augmented Humoral Response to a Third And Fourth Dose of Mrna Sars-Cov-2 Vaccines in Lung Transplant Recipients
por: Kawana, S., et al.
Publicado: (2023)

Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis
por: Kanai, Daisuke, et al.
Publicado: (2023)

The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine
por: Ul Haq, Ihtisham, et al.
Publicado: (2023)

The Breadth of Black
Publicado: (1871)

Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine
por: Li, Dapeng, et al.
Publicado: (2022)

Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy
por: Ravikumar, Rajamanonmani, et al.
Publicado: (2022)

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
por: Li, Dapeng, et al.
Publicado: (2022)

Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine
por: DeMaso, Christina R, et al.
Publicado: (2022)

Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021
por: Lehmann, Helmar C, et al.
Publicado: (2023)

Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?
por: Di Noia, Vincenzo, et al.
Publicado: (2022)

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment
por: Lasagna, A., et al.
Publicado: (2022)

Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
por: Harberts, Aenne, et al.
Publicado: (2022)

Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older
por: Saiag, Esther, et al.
Publicado: (2023)

Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review
por: Martinelli, Silvia, et al.
Publicado: (2023)

Fourth dose of COVID-19 vaccines in Israel
por: Burki, Talha Khan
Publicado: (2022)

Mosaic HIV-1 Vaccines Expand the Breadth and Depth of Cellular Immune Responses in Rhesus Monkeys
por: Barouch, Dan H., et al.
Publicado: (2010)

Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
por: Mahrokhian, Shant H., et al.
Publicado: (2022)

Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination
por: Boudreau, Carolyn M., et al.
Publicado: (2023)

Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe
por: Wagner, Ralf, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6fhr9nsrbp7tske3t3dvrtc5b2